organic compounds
of 3-bromomethyl-2-chloro-6-(dibromomethyl)quinoline
aDepartment of Chemistry, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India, bDepartment of Chemistry, University of Durham, South Road, Durham DH1 3LE, England, and cUniveristy of Bristol, Department of Chemistry, Cantock's Close, Bristol BS8 1TS, England
*Correspondence e-mail: psmohan59@gmail.com
In the title compound, C11H7Br3ClN, the quinoline ring system is approximately planar (r.m.s. = 0.011 Å). In the crystal, molecules are linked by C—H⋯Br interactions forming chains along [10-1]. The chains are linked by C—H⋯π and π–π interactions involving inversion-related pyridine rings [intercentroid distance = 3.608 (4) Å], forming sheets parallel to (10-1). Within the sheets, there are two significant short interactions involving a Br⋯Cl contact of 3.4904 (18) Å and a Br⋯N contact of 3.187 (6) Å, both of which are significantly shorter than the sum of their van der Waals radii.
Keywords: crystal structure; quinoline; bromoquinolines; halogen–halogen contacts; Br⋯Cl contacts; Br⋯N contacts; C—H⋯Br hydrogen bonds; π–π interactions.
CCDC reference: 902598
1. Related literature
The title compound is an important intermediate in the manufacture of materials such as organic light-emitting devices. For the synthesis of the title compound, see: Jones (1977); Lyle et al. (1972). For the biological activity of quinoline derivatives, see: Chauhan & Srivastava (2001); Ferrarini et al. (2000); Chen et al. (2001); Sahin et al. (2008).
2. Experimental
2.1. Crystal data
|
2.3. Refinement
|
|
Data collection: CrysAlis PRO (Oxford Diffraction, 2010); cell CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: PLATON (Spek, 2009) and Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL2014 and PLATON.
Supporting information
CCDC reference: 902598
https://doi.org/10.1107/S2056989015008002/su5096sup1.cif
contains datablocks I, Global. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S2056989015008002/su5096Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S2056989015008002/su5096Isup3.cml
The title compound was prepared in line with literature methods (Jones, 1977; Lyle et al., 1972). 2-Chloro-3,6-dimethyl-quinoline (0.001 mole) was dissolved in CCl4. To this benzoyl peroxide (50 mg) was added and the mixture was stirred under ice-cold conditions. To this mixture N-bromosuccinimide (0.005 mole) was added portion wise. The whole mixture was further stirred under ice-cold condition for 1 h. The reaction mixture was then refluxed for about 10 hours. After completion of the reaction, the succinimide was removed (it was insoluble in CCl4) by filtration and washed with 20 ml of CCl4. The contents of the filtrate were reduced to half, and the residue was chromatographed on silica gel using petroleum ether and ethyl acetate as
(99:1), which gave the titled product (yield: 52%). The white solid obtained was then recrystallized using acetone yielding colourless block-like crystals.Crystal data, data collection and structure
details are summarized in Table 1. H atoms were included in calculated positions and refined using a riding model: C—H = 0.95 - 1.0 Å with Uiso(H) = 1.2Ueq(C). The highest peak in the final difference Fourier map (1.654 eÅ-3) is close to atom Cl1. Attempts to split this atom were unsuccessful.The presence of the quinoline skeleton in the frameworks of pharmacologically active compounds and natural products has spurred on the development of different strategies for their synthesis (Chauhan et al., 2001; Ferrarini et al., 2000; Chen et al., 2001). Bromoquinolines have been of interest for chemists as precursors for
with multifunctionality, giving accessibility to a wide variety of compounds. These building blocks have been used in medicinal chemistry as starting materials for numerous compounds with pharmacological activity (Sahin et al., 2008).The molecular structure of the title compound is shown in Fig. 1. The quinoline ring is planar (r.m.s. = 0.011 Å).
In the crystal, molecules are linked by C—H···Br interactions forming chains along [101]; Table 1 and Fig. 2. The chains are linked by C—H···π (Table 1), and π-π interactions involving inversion related pyridine rings (N1/C1—C5) with an inter-centroid distance of 3.608 (4) Å, forming sheets parallel to (101). Within the sheets, there are two significant short interactions: A Br1···Cli contact of 3.4904 (18) Å and a Br3···Nii contact of 3.187 (6) Å [symmetry codes: (i) -x+3/2, y-1/2, -z+3/2; (ii) x-1/2, -y+3/2, z-1/2], both are significantly shorter than the sum of their van der Waals radii [1.85 Å for Br; 1.75 Å for Cl; 1.55 Å for N; PLATON (Spek, 2009)].
The presence of the quinoline skeleton in the frameworks of pharmacologically active compounds and natural products has spurred on the development of different strategies for their synthesis (Chauhan et al., 2001; Ferrarini et al., 2000; Chen et al., 2001). Bromoquinolines have been of interest for chemists as precursors for
with multifunctionality, giving accessibility to a wide variety of compounds. These building blocks have been used in medicinal chemistry as starting materials for numerous compounds with pharmacological activity (Sahin et al., 2008).The molecular structure of the title compound is shown in Fig. 1. The quinoline ring is planar (r.m.s. = 0.011 Å).
In the crystal, molecules are linked by C—H···Br interactions forming chains along [101]; Table 1 and Fig. 2. The chains are linked by C—H···π (Table 1), and π-π interactions involving inversion related pyridine rings (N1/C1—C5) with an inter-centroid distance of 3.608 (4) Å, forming sheets parallel to (101). Within the sheets, there are two significant short interactions: A Br1···Cli contact of 3.4904 (18) Å and a Br3···Nii contact of 3.187 (6) Å [symmetry codes: (i) -x+3/2, y-1/2, -z+3/2; (ii) x-1/2, -y+3/2, z-1/2], both are significantly shorter than the sum of their van der Waals radii [1.85 Å for Br; 1.75 Å for Cl; 1.55 Å for N; PLATON (Spek, 2009)].
The title compound is an important intermediate in the manufacture of materials such as organic light-emitting devices. For the synthesis of the title compound, see: Jones (1977); Lyle et al. (1972). For the biological activity of quinoline derivatives, see: Chauhan & Srivastava (2001); Ferrarini et al. (2000); Chen et al. (2001); Sahin et al. (2008).
The title compound was prepared in line with literature methods (Jones, 1977; Lyle et al., 1972). 2-Chloro-3,6-dimethyl-quinoline (0.001 mole) was dissolved in CCl4. To this benzoyl peroxide (50 mg) was added and the mixture was stirred under ice-cold conditions. To this mixture N-bromosuccinimide (0.005 mole) was added portion wise. The whole mixture was further stirred under ice-cold condition for 1 h. The reaction mixture was then refluxed for about 10 hours. After completion of the reaction, the succinimide was removed (it was insoluble in CCl4) by filtration and washed with 20 ml of CCl4. The contents of the filtrate were reduced to half, and the residue was chromatographed on silica gel using petroleum ether and ethyl acetate as
(99:1), which gave the titled product (yield: 52%). The white solid obtained was then recrystallized using acetone yielding colourless block-like crystals. detailsCrystal data, data collection and structure
details are summarized in Table 1. H atoms were included in calculated positions and refined using a riding model: C—H = 0.95 - 1.0 Å with Uiso(H) = 1.2Ueq(C). The highest peak in the final difference Fourier map (1.654 eÅ-3) is close to atom Cl1. Attempts to split this atom were unsuccessful.Data collection: CrysAlis PRO (Oxford Diffraction, 2010); cell
CrysAlis PRO (Oxford Diffraction, 2010); data reduction: CrysAlis PRO (Oxford Diffraction, 2010); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: PLATON (Spek, 2009) and Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL2014 (Sheldrick, 2015) and PLATON (Spek, 2009).C11H7Br3ClN | F(000) = 808 |
Mr = 428.36 | Dx = 2.279 Mg m−3 |
Monoclinic, P21/n | Mo Kα radiation, λ = 0.71073 Å |
a = 8.9042 (5) Å | Cell parameters from 4382 reflections |
b = 9.3375 (4) Å | θ = 2.6–29.0° |
c = 15.5107 (7) Å | µ = 9.88 mm−1 |
β = 104.553 (5)° | T = 120 K |
V = 1248.23 (11) Å3 | Block, colourless |
Z = 4 | 0.42 × 0.36 × 0.30 mm |
Oxford Diffraction Xcalibur Sapphire3 Gemini ultra diffractometer | 2259 independent reflections |
Radiation source: Enhance (Mo) X-ray Source | 1889 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.029 |
Detector resolution: 16.1511 pixels mm-1 | θmax = 25.3°, θmin = 2.4° |
ω scans | h = −10→10 |
Absorption correction: analytical (CrysAlis PRO; Oxford Diffraction, 2010) | k = −11→11 |
Tmin = 0.056, Tmax = 0.153 | l = −18→12 |
8597 measured reflections |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.051 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.143 | H-atom parameters constrained |
S = 1.09 | w = 1/[σ2(Fo2) + (0.0713P)2 + 10.6242P] where P = (Fo2 + 2Fc2)/3 |
2259 reflections | (Δ/σ)max < 0.001 |
145 parameters | Δρmax = 1.65 e Å−3 |
0 restraints | Δρmin = −1.19 e Å−3 |
C11H7Br3ClN | V = 1248.23 (11) Å3 |
Mr = 428.36 | Z = 4 |
Monoclinic, P21/n | Mo Kα radiation |
a = 8.9042 (5) Å | µ = 9.88 mm−1 |
b = 9.3375 (4) Å | T = 120 K |
c = 15.5107 (7) Å | 0.42 × 0.36 × 0.30 mm |
β = 104.553 (5)° |
Oxford Diffraction Xcalibur Sapphire3 Gemini ultra diffractometer | 2259 independent reflections |
Absorption correction: analytical (CrysAlis PRO; Oxford Diffraction, 2010) | 1889 reflections with I > 2σ(I) |
Tmin = 0.056, Tmax = 0.153 | Rint = 0.029 |
8597 measured reflections |
R[F2 > 2σ(F2)] = 0.051 | 0 restraints |
wR(F2) = 0.143 | H-atom parameters constrained |
S = 1.09 | w = 1/[σ2(Fo2) + (0.0713P)2 + 10.6242P] where P = (Fo2 + 2Fc2)/3 |
2259 reflections | Δρmax = 1.65 e Å−3 |
145 parameters | Δρmin = −1.19 e Å−3 |
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
x | y | z | Uiso*/Ueq | ||
Br1 | 0.63474 (10) | 0.04489 (9) | 0.60991 (6) | 0.0370 (3) | |
Br3 | 0.45280 (10) | 0.74291 (9) | 0.12751 (6) | 0.0381 (3) | |
Br2 | 0.70035 (11) | 0.53886 (11) | 0.08299 (6) | 0.0429 (3) | |
Cl1 | 0.8069 (2) | 0.38929 (19) | 0.67965 (10) | 0.0226 (4) | |
N1 | 0.7951 (7) | 0.4817 (7) | 0.5207 (4) | 0.0242 (13) | |
C1 | 0.7245 (8) | 0.3973 (8) | 0.5630 (4) | 0.0215 (15) | |
C2 | 0.5903 (8) | 0.3156 (7) | 0.5249 (4) | 0.0179 (14) | |
C3 | 0.5309 (8) | 0.3292 (7) | 0.4361 (5) | 0.0201 (14) | |
H3 | 0.4411 | 0.2763 | 0.4074 | 0.024* | |
C4 | 0.6012 (8) | 0.4213 (7) | 0.3857 (4) | 0.0175 (14) | |
C5 | 0.7359 (8) | 0.4957 (8) | 0.4305 (5) | 0.0197 (14) | |
C6 | 0.8084 (8) | 0.5892 (9) | 0.3828 (5) | 0.0274 (17) | |
H6 | 0.8991 | 0.6397 | 0.4129 | 0.033* | |
C7 | 0.7505 (9) | 0.6079 (9) | 0.2946 (5) | 0.0279 (17) | |
H7 | 0.8002 | 0.6722 | 0.2631 | 0.034* | |
C8 | 0.6160 (8) | 0.5326 (8) | 0.2483 (5) | 0.0217 (15) | |
C9 | 0.5450 (8) | 0.4423 (7) | 0.2927 (4) | 0.0201 (14) | |
H9 | 0.4555 | 0.3916 | 0.2612 | 0.024* | |
C10 | 0.5174 (9) | 0.2212 (8) | 0.5792 (5) | 0.0234 (15) | |
H10A | 0.4102 | 0.1981 | 0.5456 | 0.028* | |
H10B | 0.5120 | 0.2718 | 0.6344 | 0.028* | |
C11 | 0.5499 (9) | 0.5552 (8) | 0.1511 (5) | 0.0250 (16) | |
H11 | 0.4683 | 0.4809 | 0.1295 | 0.030* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Br1 | 0.0423 (5) | 0.0311 (5) | 0.0363 (5) | 0.0018 (4) | 0.0073 (4) | 0.0085 (3) |
Br3 | 0.0415 (5) | 0.0292 (5) | 0.0416 (5) | 0.0098 (4) | 0.0068 (4) | 0.0091 (3) |
Br2 | 0.0437 (5) | 0.0546 (6) | 0.0369 (5) | 0.0031 (4) | 0.0225 (4) | −0.0033 (4) |
Cl1 | 0.0252 (9) | 0.0296 (9) | 0.0114 (7) | −0.0033 (7) | 0.0013 (6) | 0.0017 (6) |
N1 | 0.022 (3) | 0.025 (3) | 0.024 (3) | −0.001 (3) | 0.003 (2) | 0.000 (3) |
C1 | 0.020 (4) | 0.026 (4) | 0.018 (3) | 0.001 (3) | 0.005 (3) | −0.001 (3) |
C2 | 0.019 (3) | 0.012 (3) | 0.023 (3) | 0.002 (3) | 0.007 (3) | 0.002 (3) |
C3 | 0.020 (3) | 0.012 (3) | 0.027 (4) | 0.003 (3) | 0.004 (3) | −0.001 (3) |
C4 | 0.017 (3) | 0.013 (3) | 0.024 (3) | 0.001 (3) | 0.008 (3) | −0.002 (3) |
C5 | 0.019 (3) | 0.020 (3) | 0.021 (3) | 0.002 (3) | 0.005 (3) | 0.000 (3) |
C6 | 0.018 (4) | 0.030 (4) | 0.031 (4) | −0.003 (3) | 0.000 (3) | −0.002 (3) |
C7 | 0.023 (4) | 0.033 (4) | 0.029 (4) | −0.007 (3) | 0.008 (3) | 0.004 (3) |
C8 | 0.022 (4) | 0.018 (4) | 0.026 (4) | 0.005 (3) | 0.010 (3) | 0.002 (3) |
C9 | 0.021 (4) | 0.016 (3) | 0.020 (3) | 0.001 (3) | −0.001 (3) | 0.000 (3) |
C10 | 0.024 (4) | 0.023 (4) | 0.025 (4) | 0.003 (3) | 0.008 (3) | 0.003 (3) |
C11 | 0.030 (4) | 0.021 (4) | 0.026 (4) | −0.001 (3) | 0.009 (3) | 0.004 (3) |
Br1—C10 | 1.944 (7) | C4—C9 | 1.417 (9) |
Br3—C11 | 1.948 (7) | C5—C6 | 1.404 (11) |
Br2—C11 | 1.910 (8) | C6—C7 | 1.345 (10) |
Cl1—C1 | 1.776 (7) | C6—H6 | 0.9500 |
N1—C1 | 1.286 (10) | C7—C8 | 1.419 (10) |
N1—C5 | 1.371 (9) | C7—H7 | 0.9500 |
C1—C2 | 1.416 (10) | C8—C9 | 1.343 (10) |
C2—C3 | 1.352 (10) | C8—C11 | 1.489 (10) |
C2—C10 | 1.478 (10) | C9—H9 | 0.9500 |
C3—C4 | 1.409 (10) | C10—H10A | 0.9900 |
C3—H3 | 0.9500 | C10—H10B | 0.9900 |
C4—C5 | 1.409 (10) | C11—H11 | 1.0000 |
C1—N1—C5 | 117.8 (6) | C6—C7—H7 | 119.7 |
N1—C1—C2 | 126.0 (6) | C8—C7—H7 | 119.7 |
N1—C1—Cl1 | 114.6 (5) | C9—C8—C7 | 119.9 (7) |
C2—C1—Cl1 | 119.5 (5) | C9—C8—C11 | 119.4 (7) |
C3—C2—C1 | 116.6 (6) | C7—C8—C11 | 120.7 (7) |
C3—C2—C10 | 121.5 (6) | C8—C9—C4 | 121.2 (6) |
C1—C2—C10 | 121.9 (6) | C8—C9—H9 | 119.4 |
C2—C3—C4 | 120.5 (6) | C4—C9—H9 | 119.4 |
C2—C3—H3 | 119.8 | C2—C10—Br1 | 111.0 (5) |
C4—C3—H3 | 119.8 | C2—C10—H10A | 109.4 |
C5—C4—C3 | 118.0 (6) | Br1—C10—H10A | 109.4 |
C5—C4—C9 | 118.2 (6) | C2—C10—H10B | 109.4 |
C3—C4—C9 | 123.8 (6) | Br1—C10—H10B | 109.4 |
N1—C5—C6 | 119.2 (6) | H10A—C10—H10B | 108.0 |
N1—C5—C4 | 121.2 (6) | C8—C11—Br2 | 113.3 (5) |
C6—C5—C4 | 119.6 (6) | C8—C11—Br3 | 111.2 (5) |
C7—C6—C5 | 120.5 (7) | Br2—C11—Br3 | 107.9 (3) |
C7—C6—H6 | 119.8 | C8—C11—H11 | 108.1 |
C5—C6—H6 | 119.8 | Br2—C11—H11 | 108.1 |
C6—C7—C8 | 120.6 (7) | Br3—C11—H11 | 108.1 |
C5—N1—C1—C2 | 0.4 (11) | N1—C5—C6—C7 | −178.3 (7) |
C5—N1—C1—Cl1 | −178.6 (5) | C4—C5—C6—C7 | −0.2 (11) |
N1—C1—C2—C3 | −0.7 (11) | C5—C6—C7—C8 | −0.5 (12) |
Cl1—C1—C2—C3 | 178.3 (5) | C6—C7—C8—C9 | 0.4 (12) |
N1—C1—C2—C10 | 180.0 (7) | C6—C7—C8—C11 | 178.8 (7) |
Cl1—C1—C2—C10 | −1.0 (9) | C7—C8—C9—C4 | 0.5 (11) |
C1—C2—C3—C4 | −0.2 (10) | C11—C8—C9—C4 | −177.9 (6) |
C10—C2—C3—C4 | 179.1 (6) | C5—C4—C9—C8 | −1.2 (10) |
C2—C3—C4—C5 | 1.2 (10) | C3—C4—C9—C8 | 179.4 (7) |
C2—C3—C4—C9 | −179.4 (7) | C3—C2—C10—Br1 | 103.9 (7) |
C1—N1—C5—C6 | 178.7 (7) | C1—C2—C10—Br1 | −76.8 (8) |
C1—N1—C5—C4 | 0.7 (10) | C9—C8—C11—Br2 | −131.1 (6) |
C3—C4—C5—N1 | −1.5 (10) | C7—C8—C11—Br2 | 50.5 (8) |
C9—C4—C5—N1 | 179.1 (6) | C9—C8—C11—Br3 | 107.2 (7) |
C3—C4—C5—C6 | −179.5 (7) | C7—C8—C11—Br3 | −71.3 (8) |
C9—C4—C5—C6 | 1.0 (10) |
Cg2 is the centroid of the C4–C9 ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
C11—H11···Br1i | 1.00 | 2.92 | 3.709 (8) | 137 |
C10—H10B···Cg2ii | 0.99 | 2.70 | 3.438 (8) | 131 |
Symmetry codes: (i) x−1/2, −y+1/2, z−1/2; (ii) −x+1, −y+1, −z+1. |
Cg2 is the centroid of the C4–C9 ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
C11—H11···Br1i | 1.00 | 2.92 | 3.709 (8) | 137 |
C10—H10B···Cg2ii | 0.99 | 2.70 | 3.438 (8) | 131 |
Symmetry codes: (i) x−1/2, −y+1/2, z−1/2; (ii) −x+1, −y+1, −z+1. |
Acknowledgements
HAS is grateful to the Leverhulme Trust and Durham University for financial support.
References
Chauhan, P. M. S. & Srivastava, S. K. (2001). Curr. Med. Chem. 8, 1535–1542. CrossRef PubMed CAS Google Scholar
Chen, Y. L., Fang, K. C., Sheu, J. Y., Hsu, S. L. & Tzeng, C. C. (2001). J. Med. Chem. 44, 2374–2377. Web of Science CrossRef PubMed CAS Google Scholar
Ferrarini, P. L., Mori, C., Badawneh, M., Calderone, V., Greco, R., Manera, C., Martinelli, A., Nieri, P. & Saccomanni, G. (2000). Eur. J. Med. Chem. 35, 815–826. CrossRef PubMed CAS Google Scholar
Jones, G. (1977). Quinolines, Part-I. Wiley Interscience Publication, John Wiley & Sons. Google Scholar
Lyle, R. E., Portlock, D. E., Kane, M. J. & Bristol, J. A. (1972). J. Org. Chem. 37, 3967–3968. CrossRef CAS Google Scholar
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Oxford Diffraction (2010). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, England. Google Scholar
Sahin, A., Cakmak, O., Demirtas, I., Okten, S. & Tutar, A. (2008). Tetrahedron, 64, 10068–10074. CrossRef CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.